This randomized controlled trial aims to evaluate the effects of robotic hand therapy using the Syrebo E12 soft-robotic glove compared with conventional physiotherapy on hand function and manual dexterity in children with hemiplegic cerebral palsy. Children aged 7-15 years, classified as GMFCS I-III and MACS I-III, will be recruited from multiple rehabilitation centers in Pakistan. Participants will be randomly allocated (1:1) to either robotic therapy or standard physiotherapy, receiving 45-minute sessions, three times per week for 8 weeks.

The primary outcome is functional hand performance measured by the Jebsen-Taylor Hand Function Test (JTHFT). Secondary outcomes include ABILHAND-Kids, Box and Block Test, Nine-Hole Peg Test, grip strength, and qualitative feedback. Assessments will occur at baseline, week 4, week 8, and at a 6-month follow-up. A mixed-effects repeated-measures ANCOVA will be used for analysis following the intention-to-treat principle.

Inclusion Criteria:

• Patients diagnosed with Hemiplegic type of Cerebral palsy
• Age 7 to 15 years
• Ability to understand and follow simple instructions
• Gross Motor Function Classification System (GMFCS) levels I-III (ambulatory)
• Manual Ability Classification system (MACS) I to III
• Stable medical condition (no major changes in medication or therapy in the past 3 months).

Exclusion Criteria:

• Patients with severe cognitive dysfunction.
• Fixed contractures or deformities of the upper limb that would prevent safe use of the robotic device.
• Recent upper limb surgery, botulinum toxin injection, or casting within the past 6 months.
• Uncontrolled epilepsy or other unstable medical conditions.
• Visual or auditory impairments that would interfere with assessment or therapy.